1 / 50

Cancer can give you Maths

Cancer can give you Maths. Philip K. Maini Centre for Mathematical Biology Mathematical Institute; and Oxford Centre for Integrative Systems Biology, Biochemistry Oxford. Very brief overview of cancer growth

maya-dillon
Download Presentation

Cancer can give you Maths

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cancer can give you Maths Philip K. Maini Centre for Mathematical Biology Mathematical Institute; and Oxford Centre for Integrative Systems Biology, Biochemistry Oxford

  2. Very brief overview of cancer growth • First, mutations lead to cells losing appropriate signalling responses for PROLIFERATION (cell division) and APOPTOSIS (cell suicide) • Result – a growing mass of cells

  3. mutations Approx 1mm in diameter

  4. Nutrient required Hypoxic core TAF (tumour angiogenesis factors) Avascular tumour Vascular tumour Invasion Tumour produces proteases – digest ECM Competition Normal environment: Tumour Normals Add H+ Gatenby & Gawlinski Gap

  5. T-tumour density V-vascular density Glycolytic pathway Blood flow removal Avascular Case: elsewhere Nondimensionalise: Necrotic core Proliferation zone, T = const Outside tumour

  6. Assume necrosis arises whenconstantUsing experimentally determined parameter values necrotic core arises at r = 0.1 cm [avascular case]

  7. Tumour Growth No normal tissue •Avascular tumour always reaches a benign steady state•Vascular tumour is benign if invasive if (cf Greenspan 1972) necrotic core Proliferation

  8. Results Three regimes of growth: •If rate of acid removal is insufficient, exponential growth followed by auto-toxicity benign tumour Occurs in avasculars and vasculars if • vascular tumour displays sustained growth and invades •Very small tumour – no growth (insufficient acid production to include normal cell death)

  9. Experimental results (Gatenby)

  10. PROBLEM – THE GAP PREDICTED BY THIS MODEL IS TOO BIG!!!!! • Introduce quiescent cells (it is known that excess acid induces quiescence). These cells produce very little acid (Smallbone, Gatenby, PKM in prep)

  11. Metabolic changes during carcinogenesis K. Smallbone, D.J. Gavaghan (Oxford) R.A. Gatenby, R.J. Gillies (Radiology, Arizona) J.Theor Biol, 244, 703-713, 2007

  12. Introduction • Carcinogenesis: • The generation of cancer from normal cells • An evolutionary process: selective pressures promote proliferation of phenotypes best-suited to their microenvironment Normal cellsAerobic respiration 36 ATP / glucose Cancer cells Anaerobic respiration 2 ATP / glucose

  13. Cell-environment Interactions Model DCIS Nature Rev Cancer 4: 891-899 (2004)

  14. Model Development • Hybrid cellular automaton: • Cells as discrete individuals • Proliferation, death, adaptation • Oxygen, glucose, H+ as continuous fields • Calculate steady-state metabolite fields after each generation • Heritable phenotypes: • Hyperplastic: growth away from basement membrane • Glycolytic: increased glucose uptake and utilisation • Acid-resistant: Lower extracellular pH to induce toxicity

  15. Cellular Metabolism • Aerobic: • Anaerobic: • Assume: • All glucose and oxygen used in these two processes • Normal cells under normal conditions rely on aerobic respiration alone Two parameters: n = 1/18 1 < k ≤ 500

  16. Automaton Rules • At each generation, an individual cell’s development is governed by its rate of ATP production φa and extracellular acidity h • Cell death • Lack of ATP: • High acidity: • Proliferation • Adaptation

  17. Somatic Evolution P.C. Nowell, The clonal evolution of tumour cell populations, Science, 194 (4260), 23-28 (1976)

  18. Variation in Metabolite Concentrations H+ glucose oxygen

  19. Typical Automaton Evolution t=10, normal epithelium t=100, hyperplasia O2 diffusion limit basement membrane t=250, glycolysis t=300, acid-resistance

  20. Cellular evolution was demonstrated. 1 of 3 spheroids in 15 days and 3 of 3 in 30 days demonstrated proliferating clusters of GLUT1 positive clusters of cells in normoxic regions.

  21. For further details, see Gatenby, Smallbone, PKM, Rose, Averill, Nagle, Worrall and Gillies, Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer, British J. of Cancer, 97, 646-653 (2007)

  22. Cancer Growth Tissue Level Signalling: (Tumour Angiogenesis Factors) Oxygen etc Cells: Intracellular: Cell cycle, Molecular elements Partial Differential Equations Automaton Elements Ordinary differential equations

  23. Vessels – source of nutrient (oxygen); satisfy Pries-Secomb ?????? • Viscosity – Fahraeus-Linqvist effect • Cells – to divide or not to divide? Thresholds/cell cycle • Competition – acid etc

  24. Structural adaptation in normal and cancerous vasculature (PKM, T. Alarcon, H.M. Byrne, M.R. Owen, J. Murphy) Blood vessels are not static – they respond to stimuli – mechanical and metabolic. Other stimuli are: Conducted stimuli: downstream (chemical – ATP? released under hypoxic stress) upstream (along vessel wall – changes in membrane potential through gap junctions?)

  25. Model includes the production of VEGF by cells in response to low levels of oxygen (hypoxia). VEGF is an angiogenesis factor – it produces more blood vessels.

  26. Results • No VEGF production – necrotic cores • VEGF production – extensive hypoxic regions within the tumour but few necrotic regions • Downstream signalling – tumours with smaller hypoxic regions, more homogeneous distribution of oxygen • Upstream signalling – VEGF more concentrated around the hypoxic regions

  27. Model predicts that the inhomogeneous oxygen concentration leads to lower tumour load but symmetry is broken.

  28. References • Alarcon, Byrne, PKM, JTB, 225, 257-274 (2003) -- inhomogeneous media • Alarcon, Byrne, PKM, Prog. Biophys. And Mol. Biol., 85, 451-472 (2004) • Alarcon, Byrne, PKM, JTB, 229, 395-411 (2004) – cell cycle and hypoxia • Ribba, Alarcon, Marron, PKM, Agur, BMB, 67, 79-99 (2005) – doxorubicin • Alarcon, Byrne, PKM, SIAM J. Mult. Mod. Sim, 3, 440-475 (2005) • Alarcon, Byrne, PKM, Microvascular Research, 69, 156-172 (2005) – design principles • Byrne, Alarcon, Owen, Webb, PKM, Phil Trans R Soc A, 364, 1563-1578 (2006) --review • Byrne, Owen, Alarcon, Murphy, PKM, Math Models and Methods, 16, 1219-1241 (2006) – chemotherapy • Betteridge, Owen, Byrne, Alarcon, PKM, Networks and Hetero. Media, 1, 515-535 (2006) -- cell crowding • Alarcon, Owen, Byrne, PKM, Comp and Math Methods in Medicine, 7, 85-119 (2006) – vessel normalisation

  29. Summary • Simple model for acid-mediated invasion • Hybrid model for somatic evolution • Multiscale model: effects of heterogeneity structural adaptation in vessels drug delivery (NOT COVERED TODAY)

  30. Acknowledgements • Acid/somatic evolution: Bob Gatenby, Kieran Smallbone, David Gavaghan, Mike Brady, Bob Gillies (Funded – EPSRC DTC) • Multiscale modelling: Tomas Alarcon, Helen Byrne, Markus Owen, James Murphy, Russel Betteridge (Funded – EU RTN (5th and 6th frameworks) IB, NCI Virtual Tumour)

More Related